National and Kapodistrian University of Athens
ΣΥΓΚΡΙΤΙΚΗ, ΠΡΟΓΡΑΜΜΑΤΙΣΜΕΝΗ ΚΑΙ ΑΝΟΙΚΤΗ ΕΚΤΙΜΗΣΗ ΣΥΝΔΥΑΣΜΩΝ ΚΕΦΤΑΖΕΝΤΙΜΗΣ-ΑΜΙΚΑΣΙΝΗΣ ΕΝΑΝΤΙ ΚΕΦΤΑΖΕΝΤΙΜΗΣ-ΑΜΙΚΑΣΙΝΗΣ-ΒΑΝΚΟΜΥΚΙΝΗΣ ΣΕ ΕΜΠΥΡΕΤΑ ΕΠΕΙΣΟΔΙΑ ΛΕΥΚΟΠΕΝΙΚΩΝ ΑΣΘΕΝΩΝ
Abstract
dc:descriptionTHE EFFECTIVENESS OF TWO ANTIBIOTIC COMBINATIONS HAVE BEEN COMPARED AS INITIAL EMPIRIC TREATMENT AGAINST FEBRILE NEUTROPENIC PATIENTS. CEFTAZIDIME (C, 2G X IV/DAY) + AMIKACIN (A, 0,5 G X 2 IV/DAY) VERSUS CEFTAZIDIME (C, 2 G X 3 IV/DAY)+ AMIKACIN (A, 0,5 G X 2 IV/DAY) + VANCOMYCIN (V, 0,5 G X 4 IV/DAY). SEVENTY TWO (MEN 41, WOMEN 31, MEDIAN AGE 62 YEARS). FEBRILE NEUTROPENIC PATIENTS WERERANDOMISED TO RECEIVE EITHER CA (41 PATIENTS) OR CAV (31 PATIENTS). MOST OF THE MICROBIOLOGICALLY DOCUMENTED INFECTIONS WITH BACTEREMIA WERE DUE TO GRAM NEGATIVE STRAINS (83%, PS. AERUGINOSA, E. COLI, KL. PNEUMONIAE). THERE WERE NO SIGNIFICANT DIFFERENCES BETWEEN EITHER GROUP AS FAR AS CLINICAL EVALUATION IS CONCERNED (CA: 87%, CAV: 79%, P > 0,05). SIMULTANEOUSLY, THE SYNERGISTIC ACTIVITY OF THE COMBINATION CA HAS BEEN PROVEN THROUGH THE METHOD OF KILLING CURVES AGAINST NOSOCOMIAL STRAINS OF PS. AERUGINOSA, SENSITIVE OR RESISTANT. IN CONCLUSION: 1. THERE WERE NO SIGNIFICANT DIFFERENCES BETWEEN EITHER ANTIBIOTIC COMBINATION CA VERSUS CAV. 2. IN VITRO THE SYNERGISTIC ACTION OF THE COMBINATION CA HAS BEEN PROVEN EFFECIENT AGAINST PS. AERUGINOSA NOSOCOMIAL STRAINS, SENSITIVE OR NOT. 3. VANCOMYCIN SHOULD BE ADMINISTERED TO THESE PATIENTS ONLY AFTER GRAM POSITIVE MICROORGANISMS ARE ISOLATED. IT IS A FACT THAT GRAM NEGATIVE MICROORGANISM INFECTIONS PREVAIL AMONG FEBRILE NEUTROPENIC PATIENTS IN GREECE. 4.VANCOMYCIN SHOULD NOT BE ADMINISTERED AS AN INITIAL THERAPY DUE TO ITS TONIC REACTIONS REGARDING RENAL FUNCTION. 5. FURTHER INVESTIGATION IS DEMANDED FOR SAFER CONCLUSIONS.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 1992
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Andonopoulos, Andrew
- Αντωνόπουλος, Ανδρέας
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/5278